Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Norway
/
Food, Beverage & Tobacco
Create a narrative
Aker BioMarine Community
OB:AKBM Community
3
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Create a narrative
Aker BioMarine
Popular
Undervalued
Overvalued
Community Investing Ideas
Aker BioMarine
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Lysoveta Trials And Houston Restructuring Will Expand Omega-3 Reach
Key Takeaways Expanding Omega-3 market share, new products, and major retail partnerships could significantly boost revenue and sales volumes. Centralizing resources and managing tariffs are expected to improve efficiency, reduce costs, and preserve net margins.
View narrative
NOK 49.02
FV
64.8% overvalued
intrinsic discount
10.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
6 days ago
author updated this narrative
Aker BioMarine
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Rising Regulations And High Capital Demands Will Cripple Krill Supply
Key Takeaways Stricter environmental regulations and shifting consumer preferences toward sustainable alternatives threaten both raw material supply and long-term market demand. Heavy reliance on krill products and high capital requirements expose the company to financial risk and pressure on profitability.
View narrative
NOK 48.82
FV
65.5% overvalued
intrinsic discount
11.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
Aker BioMarine
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Sustainable Demand Will Redefine Marine Omega-3 Nutrition
Key Takeaways Category-defining product launches and deep R&D investment position Aker BioMarine for premium pricing, margin expansion, and long-term revenue growth. Sustainability leadership and innovative applications support market share gains and expanded opportunities in global health and nutrition markets.
View narrative
NOK 75.11
FV
7.6% overvalued
intrinsic discount
15.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Your Valuation for
AKBM
AKBM
Aker BioMarine
Your Fair Value
NOK
Current Price
NOK 80.80
46.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-29m
378m
2015
2018
2021
2024
2025
2027
2030
Revenue US$377.7m
Earnings US$27.5m
Advanced
Set Fair Value